Similar articles

• Further tests for tumour-initiating activity: N, N-di-(2-chloroethyl)-p-aminophenylbutyric acid (CB1348) as an initiator of skin tumour formation in the mouse.

  ROE FJ, SALAMAN MH. ROE FJ, et al. Br J Cancer. 1956 Jun;10(2):363-78. doi: 10.1038/bjc.1956.42. Br J Cancer. 1956. PMID: 13364128 Free PMC article. No abstract available.
• P-(Di-2-chloroethyl) aminophenylbutyric acid (CB 1348) in the treatment of cancer.

  OLSON KB. OLSON KB. Ann N Y Acad Sci. 1958 Apr 24;68(3):1017. doi: 10.1111/j.1749-6632.1958.tb42658.x. Ann N Y Acad Sci. 1958. PMID: 13627749 No abstract available.
• Clinical experience with CB 1348 (NN-di(2-chloroethyl, -P-aminophenylbutyric acid) in the treatment of chronic lymphatic leukaemia.

  HANSEN PB. HANSEN PB. Acta Radiol (Stockh). 1957 Mar;47(3):210-16. doi: 10.3109/00016925709170889. Acta Radiol (Stockh). 1957. PMID: 13424344 No abstract available.
• Early experience with p-(N, N-di-2-chloroethyl)-aminophenylbutyric acid (CB 1348), a new chemotherapeutic agent effective in the treatment of chronic lymphocytic leukemia.

  ALTMAN SJ, HAUT A, CARTWRIGHT GE, WINTROBE MM. ALTMAN SJ, et al. Cancer. 1956 May-Jun;9(3):512-7. doi: 10.1002/1097-0142(195605/06)9:3<512::aid-cncr2820090312>3.0.co;2-o. Cancer. 1956. PMID: 13330000 No abstract available.
• [Results of therapy with chlorambucil (N,N-bis-(2-chloroethyl)-p-aminophenylbutyric acid) in lymphatic systemic diseases, reticuloses and related diseases].

  WITTE S, KANDLER T. WITTE S, et al. Med Welt. 1961 Jun 10;23:1248-54. Med Welt. 1961. PMID: 13786076 German. No abstract available.